Expertise in
9
conditions

Remi Lhoret-Rabasa

Montreal, QC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Montreal, QC, CA 

Overview

Remi Lhoret-Rabasa practices practicing medicine in Montreal, Canada.

Ms. Lhoret-Rabasa is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Low Blood Sugar, Cystic Fibrosis, and Obesity.

She is actively involved in clinical research, co-authoring 296 peer reviewed articles and participating in 18 clinical trials.

Gender

Female

Locations

Montreal, QC, Canada
Other Locations
Montreal, Canada
Ottawa, ON, Canada
Halifax, NS, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

IRCM Post-COVID-19 (IPCO) Research Clinic: a Multidisciplinary Approach to Evaluate Short and Long-term Complications of COVID-19
IRCM Post-COVID-19 (IPCO) Research Clinic: a Multidisciplinary Approach to Evaluate Short and Long-term Complications of COVID-19
Enrollment Status: Recruiting
Publish Date: April 04, 2024
Intervention Type: Other
Towards Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes With Oral Glucose at a Higher Blood Glucose Threshold
Towards Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes With Oral Glucose at a Higher Blood Glucose Threshold
Enrollment Status: Completed
Publish Date: March 05, 2026
Intervention Type: Device, Other, Drug
Study Phase: Not Applicable
Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia
Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia
Enrollment Status: Completed
Publish Date: January 08, 2026
Intervention Type: Other, Device
Study Phase: Not Applicable
Reduction of Basal Insulin to Prevent Hypoglycemia During Two Types of Exercise in Adults and Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
Reduction of Basal Insulin to Prevent Hypoglycemia During Two Types of Exercise in Adults and Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
Enrollment Status: Completed
Publish Date: November 06, 2024
Intervention Type: Other
Study Phase: Not Applicable
An Open-label, Randomized, Crossover Trial to Assess the Efficacy of Single-hormone Closed-loop System With a Rapid Acting Insulin Analogue Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation in Regulating Glucose Levels in Adults With Type 1 Diabetes
An Open-label, Randomized, Crossover Trial to Assess the Efficacy of Single-hormone Closed-loop System With a Rapid Acting Insulin Analogue Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation in Regulating Glucose Levels in Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 28, 2022
Intervention Type: Other, Drug, Device
Study Phase: Not Applicable
Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes Using Artificial Pancreas and Sodium Glucose-Linked Transporter 2 Inhibition: A Randomized Open-Label Crossover Trial.
Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes Using Artificial Pancreas and Sodium Glucose-Linked Transporter 2 Inhibition: A Randomized Open-Label Crossover Trial.
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Device, Drug, Behavioral
Study Phase: Not Applicable
Carbohydrates Under Target for Type 1 Diabetes Management
Carbohydrates Under Target for Type 1 Diabetes Management
Enrollment Status: Terminated
Publish Date: February 24, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
Treatment of Mild-to-moderate Hypoglycemia in Adults With Type 1 Diabetes: a Validation Study
Treatment of Mild-to-moderate Hypoglycemia in Adults With Type 1 Diabetes: a Validation Study
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Other
Study Phase: Not Applicable
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 12 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 12 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 11, 2020
Intervention Type: Other, Drug, Device
Study Phase: Phase 2
View 9 Less Clinical Trials

296 Total Publications

Realizing a vision to improve access to diabetes care.
Realizing a vision to improve access to diabetes care.
Journal: Diabetes & metabolism
Published: February 25, 2026

Frequently Asked Questions about Remi Lhoret-Rabasa

Is Remi Lhoret-Rabasa a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Remi Lhoret-Rabasa is classified as an Elite expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Remi Lhoret-Rabasa participate in research or clinical trials?

Yes. Remi Lhoret-Rabasa has published 296 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Remi Lhoret-Rabasa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lhoret-Rabasa's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile